novartis ag fda approves voltaren gel for pain of osteoarthritis swiss pharmaceuticals company novartis ags voltaren gel received u s regulatory approval as the first prescription treatment for pain associated with osteoarthritis the food and drug administration granted the approval for voltaren gel which is a nonsteroidal anti inflammatory medication for use in treating pain associated with osteoarthritis in joints amenable to topical treatment such as the knees and those of the hands the company said "clinical trials have demonstrated voltaren gel to be highly effective in treating osteoarthritis pain in the hands and knees which are the bodys most commonly affected joints " novartis said the u s approval was based on several studies including the results of two randomized double blind placebo controlled efficacy studies and a month safety study 
